AI Article Synopsis
- * Researchers collaborated with private practitioners to collect data and analyze the effectiveness of the influenza vaccine in preventing illness through a study design called test-negative case-control.
- * The study concluded that the seasonal influenza vaccine offered moderate to good protection, with an overall effectiveness of 59.1% against all influenza strains and 53.5% specifically against influenza B.
Article Abstract
The 2017/18 winter influenza season in Hong Kong started in early January 2018, predominated by influenza B/Yamagata. We collaborated with private medical practitioners of our sentinel surveillance system to collect respiratory specimens and clinical information from patients with influenza-like illness for estimation of the influenza vaccine effectiveness (VE) using the test-negative case-control design. We found that the overall VE was 59.1% (95%CI 41.1 to 71.8%) against all influenza and 53.5% (95%CI 35.4 to 74.6%) against influenza B. Seasonal influenza vaccine provided moderate to good protection against laboratory-confirmed influenza infection at primary care level in Hong Kong in the 2017/18 winter influenza season.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6363165 | PMC |
| http://dx.doi.org/10.1080/21645515.2018.1514222 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!